Kestra Advisory Services’s Allena Pharmaceuticals ALNA Stock Holding History

Kestra Advisory Services’s Portfolio ALNA Stock Details ALNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-164,662	Closed	-$31K	–	2281
2022 Q2	$31K	Sell	164,662 -8,500	-5%	-$1.32K	﹤0.01%	2072
2022 Q1	$40K	Buy	173,162 +11,662	+7%	+$4.83K	﹤0.01%	1969
2021 Q4	$96K	Buy	161,500 +56,500	+54%	+$44.2K	﹤0.01%	1942
2021 Q3	$95K	Buy	105,000 +32,000	+44%	+$31.3K	﹤0.01%	2060
2021 Q2	$95K	Buy	+73,000	New	+$88.4K	﹤0.01%	1956

Other funds holding ALNA

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Kestra Advisory Services's ALNA Position: Q3 2022 in Review

Kestra Advisory Services sold out of Allena Pharmaceuticals (ALNA) in Q3 2022, closing a stake of 164,662 shares — an estimated $31K sold.

Kestra Advisory Services first reported a position in ALNA in Q2 2021 and held it in 5 quarters. The position peaked at $96K in Q4 2021. 2 funds tracked by Wall St. Rank hold ALNA as of Q3 2022.

Kestra Advisory Services reported no remaining Allena Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Kestra Advisory Services sold 164,662 Allena Pharmaceuticals shares in Q3 2022, an estimated $31K.
Kestra Advisory Services first reported a position in Allena Pharmaceuticals in Q2 2021 and held it in 5 quarters.
Kestra Advisory Services's Allena Pharmaceuticals position peaked at $96K in Q4 2021.
2 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q3 2022.

Based on Kestra Advisory Services's 13F filing for Q3 2022, filed 1 Nov 2022.